Literature DB >> 31201475

Loss of dysbindin-1 affects GABAergic transmission in the PFC.

H Trantham-Davidson1, A Lavin2.   

Abstract

It has been shown that dystrobrevin-binding protein 1 gene that encodes the protein dysbindin-1 is associated with risk for cognitive deficits, and studies have shown decreases in glutamate and correlated decreases in dysbindin-1 protein in the prefrontal cortex (PFC) and hippocampus of post-mortem tissue from schizophrenia patients. The PFC and the hippocampus have been shown to play a fundamental role in cognition, and studies in dysbindin-1 null mice have shown alterations in NMDAR located in pyramidal neurons as well as perturbation in LTP and cognitive deficits. The balance between excitatory and inhibitory transmission is crucial for normal cognitive functions; however, there is a dearth of information regarding the effects of loss of dysbindin-1 in GABAergic transmission. Using in vitro whole-cell clamp recordings, Western blots, and immunohistochemistry, we report here that dysbindin-1-deficient mice exhibit a significant decrease in the frequency of sIPSCs and in the amplitude of mIPSCs and significant decreases in PV staining and protein level. These results suggest that loss of dysbindin-1 affects GABAergic transmission at pre- and postsynaptic level and decreases parvalbumin markers.

Entities:  

Keywords:  Dysbindin-1; GABA; Interneurons; Prefrontal cortex

Mesh:

Substances:

Year:  2019        PMID: 31201475      PMCID: PMC6832803          DOI: 10.1007/s00213-019-05285-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  71 in total

Review 1.  Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence.

Authors:  A Carlsson; N Waters; S Holm-Waters; J Tedroff; M Nilsson; M L Carlsson
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

Review 2.  Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders.

Authors:  Schahram Akbarian; Hsien-Sung Huang
Journal:  Brain Res Rev       Date:  2006-06-08

3.  Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.

Authors:  L M Camargo; V Collura; J-C Rain; K Mizuguchi; H Hermjakob; S Kerrien; T P Bonnert; P J Whiting; N J Brandon
Journal:  Mol Psychiatry       Date:  2006-10-17       Impact factor: 15.992

Review 4.  Cognitive deficits caused by prefrontal cortical and hippocampal neural disinhibition.

Authors:  Tobias Bast; Marie Pezze; Stephanie McGarrity
Journal:  Br J Pharmacol       Date:  2017-06-07       Impact factor: 8.739

5.  DTNBP1 genotype influences cognitive decline in schizophrenia.

Authors:  Katherine E Burdick; Terry E Goldberg; Birgit Funke; John A Bates; Todd Lencz; Raju Kucherlapati; Anil K Malhotra
Journal:  Schizophr Res       Date:  2006-10-30       Impact factor: 4.939

6.  Association of genetic variations in DTNBP1 with cognitive function in schizophrenia patients and healthy subjects.

Authors:  Ji Hyun Baek; Ji Sun Kim; Seunghyong Ryu; Sohee Oh; Jihae Noh; Woo Kyeong Lee; Taesung Park; Yu-Sang Lee; Dongsoo Lee; Jun Soo Kwon; Kyung Sue Hong
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-08-22       Impact factor: 3.568

7.  Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background.

Authors:  M M Cox; A M Tucker; J Tang; K Talbot; D C Richer; L Yeh; S E Arnold
Journal:  Genes Brain Behav       Date:  2009-02-11       Impact factor: 3.449

8.  Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus.

Authors:  S Chiba; R Hashimoto; S Hattori; M Yohda; B Lipska; D R Weinberger; H Kunugi
Journal:  J Neural Transm (Vienna)       Date:  2006-02-06       Impact factor: 3.575

Review 9.  Schizophrenia: Basic and Clinical.

Authors:  Joseph T Coyle
Journal:  Adv Neurobiol       Date:  2017

10.  DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release.

Authors:  Xiao-Wei Chen; Ya-Qin Feng; Chan-Juan Hao; Xiao-Li Guo; Xin He; Zhi-Yong Zhou; Ning Guo; Hong-Ping Huang; Wei Xiong; Hui Zheng; Pan-Li Zuo; Claire Xi Zhang; Wei Li; Zhuan Zhou
Journal:  J Cell Biol       Date:  2008-05-26       Impact factor: 10.539

View more
  4 in total

Review 1.  Advantages and Limitations of Animal Schizophrenia Models.

Authors:  Magdalena Białoń; Agnieszka Wąsik
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

Review 2.  Keeping Excitation-Inhibition Ratio in Balance.

Authors:  Sergei Kirischuk
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

3.  Schizophrenia-associated dysbindin modulates axonal mitochondrial movement in cooperation with p150glued.

Authors:  Bo Kyoung Suh; Seol-Ae Lee; Cana Park; Yeongjun Suh; Soo Jeong Kim; Youngsik Woo; Truong Thi My Nhung; Su Been Lee; Dong Jin Mun; Bon Seong Goo; Hyun Sun Choi; So Jung Kim; Sang Ki Park
Journal:  Mol Brain       Date:  2021-01-18       Impact factor: 4.041

Review 4.  Dysbindin-1, BDNF, and GABAergic Transmission in Schizophrenia.

Authors:  Rachel Jun; Wen Zhang; Nicholas J Beacher; Yan Zhang; Yun Li; Da-Ting Lin
Journal:  Front Psychiatry       Date:  2022-06-22       Impact factor: 5.435

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.